Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 43 followers
Latest posts
Last updated about 11 hours ago
Consumers remain averse to GLP-1 costs, with most unwilling to pay more than $100 out of pocket per month: KPMG
about 11 hours ago
Though Eli Lilly and Novo Nordisk have recently taken steps to make...
AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis
about 19 hours ago
The FDA granted an accelerated approval to AbbVie’s c-Met-directed ADC Emrelis as...
Sanofi hops on the US investment bandwagon with $20B commitment through 2030
about 21 hours ago
Add Sanofi to the list of drugmakers committing billions to bolster their...
Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film
about 22 hours ago
A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less...
Roche to reconsider US investment projects if Trump follows through on pricing order
about 23 hours ago
President Donald Trump's recent executive order on drug prices threatens Roche's ability...
AbbVie plant workers in Ireland threaten to strike over pay dispute: reports
about 24 hours ago
Workers at an AbbVie manufacturing facility in Carrigtwohill, Ireland, are prepared to...
Apellis' weak quarter for Syfovre signals uphill climb for geographic atrophy med: analyst
1 day ago
Apellis' geographic atrophy med Syfovre posted sales of $130.2 million for the...
Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67%
1 day ago
For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward...
CDMO Famar expands reach in Europe with acquisition of sterile manufacturing plant in Germany
1 day ago
Famar, a portfolio company of the private equity firm of MidEuropa, is...
Organon taps into ‘romantasy’ craze with new Nexplanon ad
2 days ago
Perhaps no literary genre has made quite as big of a splash...
Roche spotlights Perjeta's staying power with 10-year breast cancer survival results
2 days ago
After a decade of follow-up, Roche's Perjeta, Herceptin and chemotherapy regimen cut...
As Bayer's restructuring rolls on, Kerendia and Nubeqa power pharma unit to surprising sales increase
2 days ago
Thanks to hefty sales increases from kidney disease drug Kerendia and prostate...